Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-23971

Xla Wt + chrd.1 MO, Lee H et al. (2020)

Experiment + Assay: Xla Wt + chrd.1 MO + NF32 (in situ hybridization)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection chrd.1 MO1 chrd.1 (Xla)
NF stage 3 (4-cell)
morpholino injection chrd.1 MO2 chrd.1 (Xla)
NF stage 3 (4-cell)
Conditions:
Assay Type Assay Stages Antibody
in situ hybridization NF stage 32 to NF stage 32  
Expression Phenotypes (3):
decreased amount foxg1.L expression in forebrain
decreased amount myod1.L expression in somite
increased amount szl.L expression in ventral blood island
Source: Fig. 5 f g
Article: XB-ART-57519, PubMed